July 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 920.17 million in 2025 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
September 2026
The continuous renal replacement therapy market size was USD 1.71 billion in 2026, with leading continuous renal replacement therapy market players including baxter international inc, nikkiso co. ltd, infomed sa, Medtronic plc, bellco.
September 2026
The nicotine replacement therapy market generated USD 108.96 billion in 2026, with prominent nicotine replacement therapy companies including Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Glenmark Pharmaceuticals.
July 2026
The global hormone replacement therapy market size is projected to hit around USD 70.63 billion by 2035 from USD 39.64 billion in 2025 with a notable CAGR of 5.95%.
June 2026
The global estrogen replacement therapy market size was evaluated at USD 11.75 billion in 2025 and is predicted to hit around USD 20.49 billion by 2035, growing at a CAGR of 5.72%.
May 2026
The global gene-replacement therapy market analysis covers market size, growth drivers, key players, pipeline advances, and regulatory trends shaping future demand.
September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The global cardiac resynchronization therapy market size is projected to hit around USD 18.33 billion by 2035 from USD 9.73 billion in 2026 with a CAGR of 7.31%.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The global aromatherapy market size surpassed USD 11.10 billion in 2026 and is estimated to reach around USD 23.31 billion by 2035, expanding at a CAGR of 8.61%.
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global image-guided therapy systems market size is projected to hit around USD 11.22 billion by 2035 from USD 6.84 billion in 2026 with a notable CAGR of 5.66%.
September 2026
The home infusion therapy market size was valued at USD 45.23 billion in 2026 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
September 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The global dental consumables market size is surpassed at USD 42.65 billion in 2026 and is expected to surpass USD 84.78 billion by 2035, growing at a CAGR of 7.94%.
September 2026
The plasma derived therapy market size is accounted at USD 25.01 billion in 2026 and is expected to hit around USD 45.29 billion by 2035 with a CAGR of 6.83%.
September 2026
The global T-cell therapy market size is reached at USD 13.99 billion in 2026 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
September 2026
The end stage renal disease market was valued at USD 174.43 billion in 2026, with end stage renal disease market leading companies including Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc.,Medtronic Plc.
September 2026
The global gene therapy market size was exhibited at USD 13.24 billion in 2026 and is predicted to hit around USD 63.52 billion by 2035 with a solid CAGR of 19.09%.
September 2026
The global immunotherapy drugs market size was valued at USD 376.22 billion in 2026 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
September 2026
The global transcatheter aortic valve replacement market size is projected to hit around USD 12.92 billion by 2035 from USD 7.13 billion in 2026 with a CAGR of 7%.
September 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
September 2026
The global physical therapy software market size is estimated to hit around USD 4.16 billion by 2035 growing from USD 1.70 billion in 2026, with a solid CAGR of 10.45%.
September 2026
The global radioembolization therapy market size was evaluated at USD 1.26 billion in 2026 and is predicted to hit around USD 2.15 billion by 2035, growing at a CAGR of 7.64%.
September 2026
The global respiratory anesthesia consumables market size was evaluated at USD 2.41 billion in 2026 and is predicted to hit around USD 4.58 billion by 2035, growing at a CAGR of 7.41%.
September 2026
The global healthcare consumables market is estimated to hit around USD 231.66 billion by 2035, increasing from USD 175.29 billion in 2026, with a CAGR of 3.21%.
September 2026
The continuous glucose monitoring device market size was valued at USD 6.16 billion in 2026 and is expected to hit USD 11.23 billion by 2035, registering a CAGR of 6.94%.
September 2026
The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
September 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 9.39 billion in 2026, with a CAGR of 9.12%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com